Answer
Ceretec (exametazime) requires careful benefit–risk assessment in patients with kidney or liver impairment because increased radiation exposure is possible.
Sources for this answer
- Ceretec 500 micrograms kit for radiopharmaceutical preparationGE Healthcare Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked